Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
miR-25-3p target mRNAs are a collection of transcripts characterized by the presence of sequences complementary to the seed region of microRNA-25-3p within their 3' untranslated regions (3'UTRs). miR-25-3p is a member of the miR-106b-25 cluster and is frequently overexpressed in various malignancies, where it acts as an oncomiR by silencing tumor suppressor genes such as BIM (BCL2L11), PTEN, and FBXW7 (PubMed: 19448624, PubMed: 22508239). By downregulating these targets, miR-25-3p promotes cell proliferation, inhibits apoptosis, and facilitates epithelial-mesenchymal transition. In addition to oncology, miR-25-3p targets are implicated in cardiovascular health, particularly in regulating calcium handling via SERCA2a (ATP2A2) in the heart (PubMed: 24618804). Therapeutic intervention focuses on modulating these interactions using antagomirs to de-repress target mRNAs or mimics to enhance silencing, depending on the disease context.
MicroRNA-mediated gene silencing where miR-25-3p binds to seed-complementary sites in the 3' untranslated region (3'UTR) of target mRNAs, resulting in translational repression or mRNA decay via the RNA-induced silencing complex (RISC).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on miR-25-3p target mRNAs (miR-25-3p targets).